Cheryl R. Blanchard, Ph.D.
President and Chief Executive Officer
Keratin Biosciences, Inc.
Dr. Blanchard joined the Board of Directors of Anika Therapeutics, Inc. in August 2018. She is currently the President and Chief Executive Officer of Keratin Biosciences, Inc., a venture-backed biotechnology company developing regenerative medicine and drug delivery products created in July 2018 by the business combination of Microchips Biotech, Inc. and KeraNetics, LLC. Prior to the business combination, Dr. Blanchard was the President and Chief Executive Officer of Microchips Biotech, Inc. since 2014, and she maintained this role with the combined entity following the business combination in July 2018. Since 2012, Dr. Blanchard has also been a Principal at Blanchard Consulting, LLC which provides scientific, regulatory, and business strategy consulting services to medical device companies and private equity clients. From 2000 to 2012, she served in various officer positions of Zimmer, Inc., a medical device company focused on musculoskeletal products, including as the Senior Vice President, Chief Scientific Officer, and general manager of Zimmer Biologics. Dr. Blanchard received her M.S. and Ph.D. in Materials Science and Engineering at the University of Texas at Austin and received her B.S. in Ceramic Engineering at Alfred University. Dr. Blanchard’s qualifications for membership on the Board include her strong scientific background in biologics and regenerative medicine and her extensive experience in management, research and product development, business development, and regulatory affairs at multiple companies in the life science industry, all of which provide the Board with innovative product development and overall business management insights. Dr. Blanchard serves as a member of the Compensation Committee and a member of the Governance and Nominating Committee.